Search clinical trials for: 15-week intervention with dual-hormone closed-loop

Total 22 results

Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Type 1 Diabetes
Institut de Recherches Cliniques de Montreal
Montreal Children's Hospital of the MUHC

Completed

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp

Type 1 Diabetes

Canada
Hvidovre University Hospital
Technical University of Denmark

Withdrawn

DiaCon Dual-Hormone Closed-Loop Glucose Control

Type 1 Diabetes

Denmark
Institut de Recherches Cliniques de Montreal
McGill University; Montreal Children's Hospital of the MUHC

Completed

Comparison of Closed-loop Operation After Morning Meal With and Without Carbohydrate Counting (CLASS02)

Type-1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
Juvenile Diabetes Research Foundation

Withdrawn

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
McGill University; Montreal Children's Hospital of the MUHC; Diabetes Québec; Medtronic...

Completed

Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 Diabetes (CLASS-01)

Type 1 Diabetes

Canada
UMC Utrecht
Inreda Diabetic B.V.; Dutch National Health Care Institute

Recruiting

Dual Hormone Closed Loop in Type 1 Diabetes (DARE)

Diabetes | Diabetes Mellitus, Type 1 | Diabetes type1

Netherlands
Albert Einstein College of Medicine
Medtronic

Completed

Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

Type 1 Diabetes

United States
University of Virginia
The Paul Manning Foundation

Terminated

Pramlintide Combined With Model Predictive Control Algorithm (ALM002)

Type 1 Diabetes Mellitus

United States
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
McGill University Health Centre/Research Institute...

Active, not recruiting

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care (SEMA-AP)

Diabetes Mellitus, Type 1 | Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
Réseau de recherche en santé cardiométabolique, diabète et obésité

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy

Type 2 Diabetes

Canada
Hebrew SeniorLife
GlaxoSmithKline; Merck Sharp & Dohme LLC; National Institute on Aging (NIA)

Completed

Secondary Prevention of Osteoporosis

Osteoporosis

United States
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline; University of Washington

Completed

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Prostate Cancer | Castration-resistant, Metastatic

United States
Memorial Sloan Kettering Cancer Center
Tufts Medical Center; Lahey Clinic

Completed

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Multiple Myeloma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic Leukemia

United States, Canada, Australia, New Zealand
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States

Search clinical trials for: 15-week intervention with dual-hormone closed-loop

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations